The Global Bioburden Testing Market has experienced consistent growth, with a compound annual growth rate (CAGR) of 12-15%. This growth is driven by tightening regulatory standards and an increasing ...

Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Bioburden Testing Market Size, Share and Trends Analysis Report by Product (Consumables, Instruments), Test, Application, End-use, and Region 2024-2030" ...

The Pharmaceutical Industry has a diverse set of products all with varying level of microbial risk to patients. On the low risk extreme there are topical pharmaceuticals on the other extreme are the ...

Methods to Simultaneously Reduce Bioburden and Maintain Column Integrity, Explained Continuous bioprocessing is inevitably becoming the future of biomanufacturing. To date, several steps within a ...

Merck has launched its latest pharmaceutical bioburden and water testing product, the Milliflex Oasis® System. The system had 96 new features, which are designed to provide benefits such as: ...

As biopharma companies fine-tune their strategies for continuous bioprocessing, bioburden control has become a top priority. The approaches that worked for batch processing are inadequate for ...

Marketresearch.biz reports that the Bioburden Testing Market size is expected to be worth around USD 4.93 Billion by 2033, from USD 1.35 Billion in 2023, growing at a CAGR of 14.20% during the ...

(MENAFN- GlobeNewsWire - Nasdaq) The bioburden testing market is set to grow significantly due to increased demand in pharmaceuticals and medical devices and strict regulatory standards. Key ...

Microbial identity data can be critical for determining contamination sources. In bio/pharmaceutical manufacturing, monitoring the bioburden of raw materials, intermediates, drug substances, ...